[A study of the effects of basic fibroblast growth factor on fibrovascular ingrowth into hydroxyapatite orbital implants].
To investigate the effects of different doses of basic fibroblast growth factor (bFGF) on the fibrovascular ingrowth into hydroxyapatite orbital implants. Thirty-six New Zealand albino rabbits were divided into 4 groups, and hydroxyapatite orbital spheres were implanted into their orbits. The implants were pretreated with 0.5, 1.5 and 5.0 g/L bFGF solution respectively in 3 groups, the untreated implants were used in the control group. At the postoperative 2, 4 and 6 weeks the implants were harvested. Observers classified the extent of the fibrovascular ingrowth in a blind manner under light microscopy. Histologic studies demonstrated that postoperatively, the rate of vascularization of the implants pretreated with 1.5 and 5.0 g/L bFGF solution was significantly increased at week 2 in comparison with that of the control group. No difference was noted between the group with the implants pretreated with 0.5 g/L bFGF solution and the control group. The bFGF 1.5 and 5.0 g/L in concentration may promote the fibrovascular ingrowth into hydroxyapatite orbital implants at week 2 after the implantation.